QVT Financial LP - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 14 filers reported holding UNITED THERAPEUTICS CORP DEL in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
QVT Financial LP ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q3 2015$61,774,000
-24.5%
22,500,0000.0%2.12%
+71.1%
Q2 2015$81,808,000
+0.8%
22,500,0000.0%1.24%
-72.6%
Q1 2015$81,122,000
+32.9%
22,500,0000.0%4.52%
+48.1%
Q4 2014$61,033,000
+0.7%
22,500,0000.0%3.05%
-2.2%
Q3 2014$60,614,000
+221.0%
22,500,000
+125.0%
3.12%
+205.5%
Q2 2014$18,883,00010,000,0001.02%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q1 2015
NameSharesValueWeighting ↓
Sage Capital Management, LLC 2,500,000$4,245,0004.05%
WHITEBOX ADVISORS LLC 34,365,000$58,350,0003.08%
BASSO CAPITAL MANAGEMENT, L.P. 10,000,000$16,963,0002.96%
CAMDEN ASSET MANAGEMENT L P /CA 21,257,000$36,084,0002.17%
GRACE BROTHERS MANAGEMENT LLC 1,500,000$2,549,0002.17%
Ferox Capital Management LP 3,000,000$5,101,0001.96%
Castle Creek Arbitrage, LLC 20,700,000$35,185,0001.57%
Polar Asset Management Partners Inc. 20,000,000$34,012,0001.44%
SYMPHONY ASSET MANAGEMENT LLC 7,712,000$13,091,0001.33%
Verition Fund Management LLC 2,500,000$4,256,0000.64%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders